Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$391K Sell
4,200
-3,230
-43% -$286K 0.02% 617
2025
Q4
$597K Sell
7,430
-1,000
-12% -$83.7K 0.03% 496
2025
Q3
$823K Buy
8,430
+800
+10% +$64.4K 0.04% 405
2025
Q2
$532K Sell
7,630
-200
-3% -$11.4K 0.02% 493
2025
Q1
$389K Buy
7,830
+820
+12% +$51.8K 0.02% 560
2024
Q4
$490K Sell
7,010
-1,300
-16% -$108K 0.02% 504
2024
Q3
$871K Buy
8,310
+101
+1% +$11.8K 0.04% 371
2024
Q2
$1.17M Sell
8,209
-10
-0.1% -$1.15K 0.06% 270
2024
Q1
$917K Buy
8,219
+200
+2% +$23.8K 0.05% 326
2023
Q4
$1.04M Sell
8,019
-1,511
-16% -$208K 0.06% 273
2023
Q3
$1.55M Sell
9,530
-750
-7% -$132K 0.11% 187
2023
Q2
$1.88M Sell
10,280
-700
-6% -$101K 0.13% 163
2023
Q1
$1.46M Sell
10,980
-1,900
-15% -$223K 0.1% 205
2022
Q4
$1.02M Hold
12,880
0.07% 265
2022
Q3
$780K Hold
12,880
0.06% 296
2022
Q2
$706K Buy
12,880
+1,550
+14% +$89.8K 0.05% 332
2022
Q1
$856K Buy
11,330
+350
+3% +$23.9K 0.05% 326
2021
Q4
$819K Buy
10,980
+3,180
+41% +$188K 0.05% 335
2021
Q3
$367K Sell
7,800
-200
-3% -$8.7K 0.02% 534
2021
Q2
$323K Sell
8,000
-1,500
-16% -$62.1K 0.02% 544
2021
Q1
$390K Buy
+9,500
New +$354K 0.03% 453

Other funds holding ACLS

Moors & Cabot's ACLS Position: Q1 2026 in Review

Moors & Cabot reduced its Axcelis (ACLS) stake by 43% in Q1 2026, selling an estimated $286K and leaving 4,200 shares worth $391K. The position accounts for 0.02% of the portfolio, ranked #617.

Moors & Cabot first reported a position in ACLS in Q1 2021 and has held it in 21 quarters since. The position peaked at $1.88M in Q2 2023. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • Moors & Cabot held 4,200 shares of Axcelis worth $391K as of Q1 2026.
  • Moors & Cabot sold 3,230 Axcelis shares in Q1 2026, an estimated $286K.
  • Axcelis made up 0.02% of Moors & Cabot's portfolio in Q1 2026, its #617 holding.
  • Moors & Cabot first reported a position in Axcelis in Q1 2021 and has held it in 21 quarters since.
  • Moors & Cabot's Axcelis position peaked at $1.88M in Q2 2023.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Moors & Cabot's 13F filing for Q1 2026, filed 8 May 2026.